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Abstract
Fluoride/proton antiporters of the CLCF family combat F− toxicity in bacteria by exporting this 
halide from the cytoplasm. These transporters belong to the widespread CLC superfamily but 
display transport properties different from those of the well-studied Cl−/H+ antiporters. Here we 
report a structural and functional investigation of these F−-transport proteins. Crystal structures of 
a CLCF homologue are captured in two conformations, with simultaneous accessibility of F− and 
H+ ions via separate pathways on opposite sides of the membrane. Manipulation of a key 
glutamate residue critical for H+ and F− transport reverses anion selectivity of transport; 
replacement of the glutamate with glutamine or alanine completely inhibits F− and H+ transport 
while allowing rapid uncoupled flux of Cl−. The structural and functional results lead to a 
‘windmill’ model of CLC antiport wherein F− and H+ simultaneously move through separate ion-
specific pathways that switch sidedness during the transport cycle.
Many species of bacteria resist the toxicity of environmental fluoride by expelling this 
xenobiotic halide from the cytoplasm via proton-coupled F− antiporters1,2. These exclusively 
bacterial “CLCF ” transporters appear in a distinct clade of the ubiquitous CLC superfamily 
of anion transport proteins, and they display two striking features not seen in the long-
studied Cl−-transporting CLCs. First, CLCFs uniquely lack the conserved Cl−-coordinating 
serine residue that governs selectivity among anions3,4. Instead, a methionine residue in the 
equivalent region, strictly conserved within a CLCF subclade, contributes to F− specificity 
by an unknown mechanism5. Second, the CLCFs are more strongly proton-driven than 
conventional CLCs, with 1:1 anion/proton stoichiometry2 rather than the 2:1 value observed 
in all Cl−-transporting homologues examined6. This report supplements the currently sparse 
landscape of CLCF antiporters by probing a homologue with functionally revealing 
mutations and solving crystal structures of the transporter and two mutants. The new 
structures, globally similar to conventional CLCs, differ from them in showing two 
previously unseen conformations: inward-open to F−//outward-open to H+, and inward-open 
to H+//outward-occluded to F−. They also capture two rotamers of the H+-coupling ‘gating 
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glutamate,’ where point-mutations unexpectedly invert the transporter’s normal F− over Cl− 
selectivity. The results taken together suggest a novel rotary mechanism of F−/H+ antiport.
RESULTS
The CLCF homologue “Eca” from Enterococcus casseliflavis provides a biochemically 
tractable exemplar of these F−-handling antiporters5. Eca differs from conventional Cl−-
transporting CLCs in its 1:1 anion-to-proton stoichiometry and its strong selectivity for F− 
over Cl−2,5. These features raise basic questions. Does the critical “gating glutamate” (E118 
in Eca), an essential, extracellularly positioned H+-transfer residue in Cl−/H+ antiporters6–9, 
also serve this purpose in the CLCFs? How is proton coupling achieved in CLCFs, which 
uniformly lack the intracellular-facing glutamate also required for H+ transfer in many Cl−/H
+
 antiporters10,11? Does the conserved methionine residue (M79 in Eca) contribute to F− 
selectivity by replacing the critical serine that along with a conserved tyrosine coordinates 
Cl− at an ‘internal gate’ of previously examined CLCs? Indeed, does this phylogenetically 
remote clade even use a F−-coordinating tyrosine, which cannot be identified in the poor 
sequence alignments in this region? In other words, are the functional and sequence oddities 
of the F− transporters manifested in the structures of these proteins in a coherently readable 
way?
The gating glutamate in CLCF crystal structures
We first examine the role of the gating glutamate (Glug) in proton coupling by asking, as 
with conventional CLCs12,13, how point substitutions at this position affect F−: H+ transport-
stoichiometry. Ion fluxes are quantified in Eca-reconstituted liposomes pre-loaded with high 
F− and suspended in low F− (Fig 1a). Equimolar F− efflux and H+ influx in wildtype (WT) 
Eca confirms its 1:1 stoichiometry, and similar experiments with Glug mutant E118D (Fig 
1b) establish a 10-fold lower transport rate and weaker coupling, with ~2:1 stoichiometry. 
However, non-dissociable mutants E118A,Q produce a completely unexpected, even 
alarming, result: inversion of ion selectivity. Neither mutant transports F−, and instead both 
pass Cl− at over twice the WT rate for F−, without concomitant H+ movement (all rates 
reported in Table 1). Since this result has no analogous precedent among Cl− CLCs, it raises 
suspicions that previous CLC crystal structures may be inadequate templates for interpreting 
functional behaviors of the phylogenetically distant CLCF proteins.
Accordingly, a crystal structure at 3.0 Å resolution of homodimeric Eca was solved in 
complex with a “monobody” crystallization chaperone14 that does not affect transport 
activity (Fig 2a, b, Supplementary Fig 1, Table 2). As expected from known CLC structures, 
each Eca subunit shows extracellular and intracellular aqueous vestibules impinging upon a 
polar but largely anhydrous ion-coupling region in the center of the protein 6–8 Å in length 
(Fig 2c). The protein’s fold mirrors other CLCs (Supplementary Fig 2a), but several of its 16 
helices are shorter than their counterparts, and some are imprecisely aligned to them. The 
αA and αR helices of the Cl− CLCs are absent in Eca (we retain conventional CLC helix 
labels, starting with helix αB), and the equivalent residues of the C-terminal αR-helix trace 
a well-ordered but meandering extended backbone trajectory.
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Two F− ions, F−ex and F−cen, appear in each Eca subunit located at the “external” and 
“central” sites in the canonical anion-binding region observed in all CLCs, roughly halfway 
across the membrane. These densities may be confidently assigned as F− ions rather than 
isoelectronic waters from their congruence with Cl−ex and Cl−cen in structural alignments 
(Supplementary Fig 2b), and since many of their coordinating residues match those known 
in the Cl− CLCs (Fig 3). For instance, both F−ex and Cl−ex are mainly embraced by 
backbone amides in equivalent stretches of sequence (G116-G119 in Eca, G146-G149 in 
CLC-ec1), as well as by the positive dipoles of the N-termini of helices αF and αN in both. 
Moreover, the tyrosine hydroxyls coordinating the central anions in the F− and Cl− 
transporters coincide precisely (Y396 in Eca, Y445 in CLC-ec1). Although the resolution 
here is too low to quantify F− occupancy values, precedent from other CLC structures7 and 
the clear difference densities of these light ions suggest simultaneous occupancy of both.
In Cl−-transporting CLCs, the Glug sidechain has been variously observed in three rotameric 
positions proposed as intermediates in the transport cycle6,9,15: ‘Down’, wherein the 
deprotonated carboxylate group displaces Cl− from the central anion site, ‘Middle’, where 
also deprotonated it occupies the external site, and ‘Up’, extended such that the carboxyl 
group reaches for the extracellular solution, with Cl−ex and Cl−cen simultaneously occupying 
both sites. The Up-configuration has been seen only with the protonated surrogate glutamine 
substituted at this position, never with glutamate, whose carboxyl group, when deprotonated, 
seeks the electropositive anion-binding sites. But in WT Eca, Glug adopts the Up-rotamer 
(Fig 3a), allowing both F− ions to occupy the transport sites; its protonation state is unknown 
under these pH 6 crystallization conditions.
The profound reversal of ion selectivity in E118Q would seem to anticipate a corresponding 
structural alteration. However, a crystal structure of this mutant (Fig 3c, Supplementary Fig 
1, Table 2) fails to show any significant differences with WT. The appearance of F− ions at 
the same sites as in WT motivated flux experiments (Fig 4) showing that Cl− transport in this 
mutant is strongly blocked by F− (Ki = 20 μM in the presence of 140 mM Cl−). This effect 
provides a proxy for F− binding, at least 10-fold stronger than in WT, as observed previously 
by isothermal titration calorimetry (ITC)5 and confirmed here (Supplementary Fig 3). While 
these blocking experiments demonstrate tight F− binding to the mutant’s transport 
machinery, they provide no information about where the ion binds - to the external site, the 
central site, or both. Unfortunately, we could not obtain ITC heat signals with E118Q or 
diffraction-quality crystals formed in F−-free Cl− solutions.
In conventional CLCs, the Up position of Glug - previously observed only with substituted 
Gln - is widely considered to represent an outward-open state of the transport cycle. In this 
view, binding sites for Cl−cen, Cl−ex, and H+ enjoy access to extracellular solvent, either 
unfettered or accompanied by subtle pH-dependent backbone movements7,16,17, while 
intracellular access is prevented by a “gate” formed by Cl−-coordinating sidechains of 
conserved Ser and Tyr at the central site15,18,19. This picture is completely inverted in the 
CLCF structure. Now for the first time Glug appears in the Up-configuration, its carboxyl in 
direct exchange with extracellular protons; remarkably, the anion-binding sites are 
accessible only to intracellular solvent, via a wide aqueous vestibule leading to F−cen bound 
at its apex and F−ex ~6 Å behind it (Fig 2c). Extracellular access to both ions is blocked off 
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primarily by a stretch of extended sequence in conserved residues immediately preceding 
Glug (S114-R117), unlike the more open pathway in conventional CLCs. The Up-
configuration of Glug positions it far away from the intracellular side of the protein. This 
antiporter conformation is simultaneously accessible to extracellular H+ (but not F−) and to 
intracellular F− (but not H+).
Coordination of F− ions
Since numerous F−-coordinating moieties in Eca match those in the Cl− CLCs, the new 
structures provide no immediate explanation for the unusual F− specificity of the CLCFs. 
The coordination of F−ex, mostly by backbone amides, is similar to the surround of Cl−ex in 
other CLCs, except for the sidechain of T320, whose hydroxyl group hovers ~4 Å away 
from F−ex (Fig 3). It is F−cen that is differently clothed. The strictly conserved Cl−cen-
coordinating central serine residue in the conventional CLCs is missing in the CLCFs, and in 
a roughly equivalent position lies a conserved Met residue (Met79), suggested from 
sequence-gazing and confirmed by mutagenesis as a F− selectivity determinant2,5. It is 
particularly notable that its terminal methyl and γ-methylene groups, rendered weakly 
electropositive by proximity to the δ-sulfur, are positioned near F−cen, since this arrangement 
quite precisely reprises F− coordination in a functional Met mutant of a F−-specific ion 
channel20. In addition, the coordination of F−cen by the hydroxyl of Y396 establishes this 
residue as equivalent to the inner-gate tyrosine that coordinates Cl−cen in Cl− CLCs (Y445 in 
CLC-ec1). This same Tyr does double-duty by also orienting its aromatic ring to approach 
this same F− edge-on, an electropositive quadrupolar interaction previously observed in the 
only other known F− transport protein family, the Fluc ion channels21,22. An additional 
oddity of the F−cen coordination sphere is a close contact (3.3 Å) with the carboxyl group of 
E318, which has no counterpart in conventional CLCs. Beyond its involvement in F− 
coordination, it is conspicuous from its location at the top of the intracellular cavity, close to 
where the carboxylate of Glug would be in its Down position, suggestive of a critical H+-
handoff function. We suppose that in this configuration E318 is a protonated H-bond donor 
to F−cen. The position of F−cen at the top of the intracellular vestibule implies that it is also 
partly hydrated by crystallographically invisible bulk waters.
Functional tests of structure-based suggestions
The CLCF structure thus identifies three previously unsuspected residues contributing to F− 
coordination: Y396, E318, and T320, the latter two without equivalents in the Cl− CLCs. 
Mutants at these positions were constructed to gauge their effects on F− transport rate, 
proton coupling, and anion specificity using liposome flux experiments. The mutants 
(Y396A, E318Q/A, T320A) express similarly to WT and show dimeric, homogeneous size-
exclusion profiles. All give qualitatively similar results: 4–20-fold inhibition of F− transport 
rates, specificity for F− with no Cl− permeation, and retention of proton coupling with 
respectable stoichiometry between 1:1 and 2:1 (Table 1). The full preservation of proton 
coupling in Y396A is particularly surprising, since the equivalent mutant in a Cl−-
transporting CLC is severely uncoupled18. These facts rule out a few obvious mechanistic 
suggestions irresistibly arising from the structure: that E318 might be a required way-station 
for H+ transit, that Y396 might determine F− selectivity and H+ coupling, and that H-bond 
donation to F− by T320 might be necessary for proper antiport behavior.
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Having failed to eliminate F−/H+ coupling by the sidechain substitutions above, we 
wondered if a Hail-Mary maneuver - glycine substitutions of residues coordinating F−ex 
through backbone amides - might enhance conformational flexibility in this region and 
thereby place a thermodynamic penalty on F− binding. All such mutants severely impair 
function except for one, V319G, which only modestly inhibits transport rate (3-fold), 
weakens H+ coupling 2-fold, and preserves F− specificity (Table 1). In addition, ITC 
experiments show 5-fold decreased F− binding affinity of the mutant (KD = 1 mM) 
compared to WT (Supplementary Fig 3). This mutant apparently allows an ‘extra’ F− ion to 
sneak through the transport cycle unaccompanied by proton counter-transport, perhaps due 
to its weakened binding; however, we cannot distinguish such ‘slippage’ from a fundamental 
change in mechanism to a tight 2:1 F−/H+ coupling.
Structure of an occluded, ion-swapped configuration
The altered F− affinity of V319G combined with its overall maintenance of F−-specific 
antiport motivated us to crystallize this mutant. The resulting structure reveals an unexpected 
conformation (Fig 5a, Supplementary Fig 4, Table 2). Here, Glug adopts the Down position, 
replacing F−cen in the central anion-binding site and thereby blocking off the intracellular 
access to F−ex seen in WT, a configuration similar to that observed in a eukaryotic CLC 
antiporter15. The Down rotamer has not been previously observed in any bacterial CLC 
structures but has been proposed as an essential, universal intermediate in the CLC antiport 
cycle9. In this configuration, backbone atoms around the mutated residue remain unmoved 
from WT positions. F−ex, the sole F− ion in the structure, having moved ~1.5 Å toward the 
extracellular side, is now occluded. This small outward displacement changes the ion’s 
coordination; it loses the mutated residue’s backbone amide and gains a short (2.6-Å) H-
bond from T320, as well as an edge-on aromatic quadrupole from F158, which moves in to 
fill the space vacated by Glug’s 7.5- Å excursion from its Up position (Fig 5a). Although the 
F− ion appears shallowly buried, Glug is not; its carboxyl group now directly faces the 
intracellular vestibule, where it is free to exchange solvent protons, a proton accessibility 
that is flipped compared to the WT structure (Fig 5b).
DISCUSSION
These experiments have uncovered several unexpected characteristics of a F−/H+ antiporter, 
characteristics we surmise on the basis of a functional survey5 to be general within this clade 
of bacterial CLCs. First, removal of the Glug carboxyl group brings about a profound 
reversal of transport specificity, allowing uncoupled Cl− passage and abolishing F− transport. 
The F−-binding experiments argue that F− fails to permeate these mutants because it binds 
too strongly, so as to retard ion dissociation at an unknown step in the transport cycle. This 
inhibitory anion-binding effect recalls analogous observations in Cl− CLCs23,24. Enhanced 
binding affinity is likely due to the ion-coupling region’s inherently electropositive 
character, which is strengthened by the uncharged Glug substitutions. The reason why Cl− 
does not permeate WT Eca remains unexplained, although it is possible that its weak 
binding affinity5 prevents it from displacing the deprotonated Glug carboxylate from an 
anion-binding site, thus locking the cycle at some step. We note, however, that if sufficiently 
high voltage is applied to WT Eca, Cl− can be driven through the protein5; to avoid that 
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complication, all flux experiments here were performed at zero voltage, where Cl− is 
negligibly permeant.
A second conclusion solves a longstanding puzzle: how can CLCFs, as well as some 
conventional CLCs15,25, dispense with the special internal glutamate (E203 in CLC-ec1) 
necessary in many Cl−/H+ antiporters for transferring intracellular protons to the ion-
coupling region via transient water-wires10,11,26,27? The V319G structure provides the 
answer, at least for Eca. A wide intracellular aqueous vestibule leading to Glug’s carboxylate 
in the Down position allows proton exchange directly with solvent.
A third conclusion, both surprising and revealing, arises from comparisons of WT and 
V319G structures (Fig 5b). We view these as representing two novel conformations, 
mechanistically intriguing for an antiporter, in which F− and H+ are simultaneously 
accessible to their transport sites via separate pathways from opposite sides of the 
membrane. In WT, the Glug sidechain is captured in the Up-position, its carboxylate exposed 
to the extracellular aqueous vestibule, where it can readily exchange protons; this same 
conformation blocks bound F− ions from extracellular access while exposing them to 
intracellular solvent. The V319G structure inverts this accessibility, with Glug Down and H+ 
in easy intracellular exchange, while the F−ex ion is occluded in a more external location; its 
occlusion, however, appears fragile, such that the anion might gain access to extracellular 
solution through sidechain dynamics or the small backbone movements previously inferred 
for Cl− CLCs16,17. We therefore designate the mutant’s configuration “extracellular-
occluded”. Because the Down-configuration of Glug in the functionally competent V319G 
mutant is identical to that observed in a eukaryotic Cl− CLC15, and since its existence in a 
prokaryotic Cl− CLC is supported by flux experiments9, we consider it to represent a 
relevant, on-pathway configuration rather than a mutagenic perversion.
These conclusions lead immediately to a picture of the antiporter switching between two 
conformations of opposite sidedness, each with separate pathways for the functionally 
entwined ions (Fig 6a). Each conformation presents pathways connecting the ions from the 
center of the protein to solvent on opposite sides of the membrane. The structures suggest 
that F− (but not H+) can enter the protein from the inside only when H+ (but not F−) can 
enter from the outside, and after the conformational switch, F− can leave to the outside only 
when H+ can leave to the inside. This picture fundamentally differs from the conventional 
ping-pong antiport mechanism (frequently misnamed “alternating access”) by which many 
transporters operate, wherein the coupled substrates bind in a mutually exclusive fashion. 
Here in contrast, the coupled ions occupy their transport sites simultaneously at certain steps 
in the cycle, as in other proposed CLC mechanisms.
The CLCF structures, assuming them on-pathway, taken along with the functional results, 
are difficult to reconcile with the piston-like movements acting in the numerous variations of 
Cl− CLC mechanisms previously proposed9,15–17,28–30. In such models, the deprotonated 
Glug sidechain in its Up-position pushes both Cl− ions inward as it displaces them from their 
sites, and then, after protonation from intracellular solution, withdraws via the same 
pathway.
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We propose instead a “windmill” model, in which alternate conformations with ion 
pathways swapping sidedness lead naturally to coupled antiport (Fig 6b). In accordance with 
all known CLC crystal structures, the model requires both transport sites to be always 
occupied by anions - either F− or deprotonated Glug. The transport cycle is depicted with ion 
gradients favoring net F− export, its physiological task. The cycle starts with a fully loaded 
protein, with both F− sites filled and Glug protonated (top image). The carboxyl-bearing 
sidechain, performing rotameric gymnastics (Supplementary Fig 5), rotates clockwise from 
its Up position around the F−ex ion without displacing it to occupy the central site in the 
Down position (Step 1). This movement delivers both F−cen and a proton to the intracellular 
solution. The cycle continues (Step 2) as the sidechain, now deprotonated, withdraws to the 
Middle position, chasing F−ex off its site to the extracellular side, while intracellular F− 
returns to refill the central site. We assume that this step opens the extracellular pathway 
enough to allow F−ex to be expelled outward by Glug. Although our Eca structures do not 
include this sidechain-anion configuration, we nevertheless consider it a plausible 
intermediate since it appears in nearly all known Cl− CLC structures. Finally (Step 3), 
deprotonated Glug returns to the Up position, continuing through the anion-friendly pathway 
that it had previously circumvented in its protonated state, while F−cen moves upward to the 
external site and an intracellular F− ion follows into the vacated central site. Net movement 
in the cycle is thus one proton inward and one F− outward, with the protonated sidechain’s 
‘downward’ path distinct from its deprotonated ‘upward’ movement via the anion-binding 
sites: a clockwise rotary trajectory. Of course, all steps are reversible, so if electrochemical 
gradients would instead favor net inward movement of F−, Glug would rotate 
counterclockwise. This mechanism rationalizes the low transport rate of E118D, whose 
shorter sidechain impairs these rotameric contortions. It also explains inhibition of F− 
transport in the electrostatically neutered Glug mutants, as efficient ejection of tightly bound 
F−ex requires an anionic Glug; this latter point leads us to conjecture that Cl− may permeate 
these mutants simply as a result of its weaker binding and absence of competition from the 
Glug carboxylate.
The mechanism proposed here leaves many questions unanswered. What are the affinities of 
the two F−-binding sites in the conformations observed? Why does Cl− easily permeate the 
Glug mutants but not WT? At which step does high voltage act on WT to force Cl− through 
the transporter5? How does Met79 influence F− selectivity? Finally, we emphasize that in 
light of the unique 1:1 stoichiometry of the CLCFs, the windmill mechanism is proposed 
only for this antiporter clade. We remain agnostic as to whether it applies to the CLC 
superfamily in general; about that question, the experiments here are silent.
Methods
Reagents
All chemcals were purchased at the highest grade from Sigma-Aldrich or Thermo Fisher. n-
decylmaltoside (DM), n-decylphosphocholine (fos-choline-10), and 3-[(3-cholamidopropyl)-
dimethylammo-nio]-1-propane sulfonate] (CHAPS) were obtained from Anatrace (Maumee, 
OH), and E. coli polar phospholipids (EPL) were from Avanti Polar Lipids (Alabaster, AL). 
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K-isethionate solutions were prepared by titrating isethionic acid (Wako Pure Chemical 
Industries, Osaka, Japan) with KOH.
Protein expression, purification, and functional reconstitution
The Eca CLCF construct used here from Enterococcus casseliflavus (GenBank 
EEV30821.1) contains three N-terminal alanines arising from the cloning site, but residues 
are numbered according to the WT sequence, ignoring this insertion. The “WT” background 
construct, on which all mutants were made, contains a M4I mutation to remove a possible 
alternative start codon. All Eca proteins carry an uncleaved C-terminal hexahistidine tag 
preceded by a GSGG linker. Eca was expressed from vector pASK90 with a tetracycline 
promoter31, and all mutations were made via standard PCR techniques.
Eca was expressed in BL21(DE3) cells. In brief, transformed cells were grown at 37 °C to 
~0.8 OD in terrific broth and induced with 0.2 μg/mL anhydrotetracycline for 3 hr. Cells 
were harvested by centrifugation, and the pellets were resuspended in 100 mM NaCl, 50 
mM tris pH 7.5 with DNAse and lysozyme. Cells were sonicated, and Eca was extracted 
with 4% DM for 2 h at room temperature. Samples were then centrifuged to pellet insoluble 
material and loaded on Talon cobalt resin (Takara Bio, Kusatsu, Japan) equilibrated with 100 
mM NaCl, 5 mM DM, 20 mM tris pH 7.5. Protein was washed and eluted sequentially with 
40 mM and 400 mM imidazole in the above buffer. The protein was concentrated and 
purified over a Superdex 200 Increase size-exclusion column (GE Healthcare) equilibrated 
with either 25 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), 100 mM 
NaCl, 5 mM DM, pH 7 (functional assays), or 10 mM HEPES, 100 mM NaF, 5 mM DM, 
pH 7 (crystallography). Eca for isothermal titration calorimetry was prepared as above, 
except that the Talon equilibration buffer was 10 mM HEPES, 100 mM Na/K tartrate, 2 mM 
NaCl, 5 mM DM, pH 7.5, and the Superdex-ITC buffer was 10 mM HEPES, 100 mM Na/K 
tartrate, 5 mM DM, pH 7.0.
Proteoliposomes were formed by mixing purified Eca with 10–20 mg/mL stocks of EPL 
solubilized with 30–40 mM CHAPS. Protein/lipid mixtures were extensively dialyzed using 
10 kDa MWCO Slide-A-Lyzer cassettes (Thermo Fisher) against 150 mM 3-(N-
morpholino)propanesulfonic acid (MOPS) pH 7.5 with either 150 mM KF or 150 mM KCl. 
Proteoliposomes were freeze-thawed 3x prior to use. For F− blocking experiments (Fig. 4) F
−
 at the reported concentration was added to KCl-dialyzed proteoliposomes prior to the 
freeze-thaw cycles. Final protein/lipid ratios were 3–15 μg protein/mg lipid.
The monobody crystallization chaperone “X1” (Supplementary Fig 6) was selected from a 
phage display library as described14, and mutated slightly to improve crystal contacts. It was 
expressed from a pHFT2 vector in BL21(DE3) cells. Transformed cells were grown to OD 
0.8 in terrific broth at 37 °C and induced 3 hr at 30°C with 0.2 mM isopropyl β-D-1-
thiogalactopyranoside. Cells were harvested and sonicated as above. Sonicated cells were 
clarified by centrifugation and loaded on Talon cobalt resin by batch binding for 3 h. The N-
terminal hexahistidine tag was removed by on-column cleavage by overnight incubation 
with TEV protease (0.2 mg/L of cell culture). Cleaved monobody was rinsed off the column 
with equilibration buffer, concentrated, and purified over a Superdex 75 Increase column 
equilibrated with 10 mM HEPES, 100 mM NaF, pH 7.
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Ion flux measurements
Liposomes loaded with either 150 mM KF or KCl were extruded through 0.4 μm 
membranes (Whatman) and 100 μL were centrifuged over a 1.5 mL Sephadex G-50 column 
equilibrated with flux-assay buffer (1 mM MOPS pH 7.5, 150 mM K-isethionate, 123 mM 
Na-isethionate). Liposomes were diluted into a stirred beaker containing flux buffer 
supplemented with either 1 mM KF or 1 mM KCl for F− or Cl− conditions5. For F− blocking 
experiments, KF at the reported concentration was present on both sides of the liposome 
membrane. Flux was initiated by the addition of 0.9 μM valinomycin. Appearance of ions in 
the liposome suspension was followed continuously with F−, Cl−, or H+-specific electrodes 
in a stirred cell. Reported initial flux rates were calculated 2–10 sec after adding 
valinomycin, and are corrected for the background leakage through protein-free liposomes.
Isothermal titration calorimetry
Isothermal titration calorimetry was performed as previously described5, with both protein 
and F− in the above Superdex-ITC buffer. Measurements were made in a TA Instruments 
(New Castle, DE) Nano-ITC. Protein (170 μL) at ~30–250 μM was titrated with 2 μL 
injections of 5–30 mM KF at 25 °C, and data were fit to single-site isotherms.
Crystallography
Purified Eca and monobody X1 were concentrated and mixed to a final protein stock of 10 
mg/mL Eca and 2.8 mg/mL monobody, supplemented with 11 mM fos-choline-10. Crystals 
were formed via the sitting-drop vapor diffusion method, with drop mixtures containing 
between 1 and 3 μL of protein and well solution mixed in equal volume. Well solutions 
consisted of 100 mM K-formate, 100 mM 2-[(2-amino-2-oxoethyl)-
(carboxymethyl)amino]acetic acid (ADA) pH 6.0 or 6.2, and 20–24% PEG600. Crystals 
were incubated for ~5 weeks at 22 °C. Serial additions of cryoprotectant were required, 
consisting of 27%, 29%, and 34% PEG600 in solutions matching the final crystal solution. 
The initial drop volume of 27% PEG600 was first slowly added, followed by 2x the initial 
volume of 29% PEG600, and 4x the initial volume of 34% PEG600. Crystals were then 
picked with cryo loops and frozen in liquid nitrogen.
Datasets were collected at the Advanced Light Source beamlines 5.0.1 and 5.0.2. Frames 
were integrated, scaled, and merged using Xia2/DIALS/Aimless32–34. Molecular 
replacement of WT Eca was done in PHASER35, using as search model CLC Cl−/H+ 
antiporter from Synechocystis sp. (PDB# 3Q17 chain B) trimmed with Chainsaw36 based 
upon a sequence alignment from AlignMe37. The two monobodies were then placed using 
chain E from PDB# 5FXB, manually trimmed to remove regions of differing sequence. 
Molecular replacement for the mutant structures was done using the refined WT structure. 
Structure were refined using phenix.refine38 and Refmac539, with final refinement done in 
Phenix. TLS and torsion-angle NCS restraints were used for all structures. V319G and 
E118Q refinement used reference model restraints against the final WT monobody chains, 
but not the Eca chains. Real-space refinement was done in COOT40. Extent of F− accessible 
vestibules was calculated in HOLLOW41.
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Statistics and reproducibility
In plots and Table 1, rates report mean ± s.e.m. of 3–6 repeats and of at least two 
independent protein preps. ITC experiments (illustrated in Fig SI 3) were repeated three 
times.
Data availability
Crystallographic data are deposited in the Protein Data Bank: WT Eca (PDB 6D0J), E118Q 
(PDB 6D0K), V319G (PDB 6D0N). Source data for Figs 3d, 4b and 4c and Supplementary 
Fig 3 are available on request.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Ion transport for Eca and ion-coupling mutants
a. Cartoon depicting liposomal F−/H+ antiport assay (left), and a recording illustrating WT 
ion fluxes (right). b. F−, Cl−, and H+ fluxes for Glug mutants. H+ flux was measured under F
−
 conditions for WT and E118D and Cl− conditions for E118Q/A. Upward/downward 
signals indicate appearance/disappearance of indicated ions from proteoliposome 
suspension. Turnover is reported as ions/Eca subunit.
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Figure 2. Structure of CLCF-Eca
a. Asymmetric unit, showing a single Eca homodimer (yellow, wheat) with two monobody 
chaperones (pink) bound to extracellular surface and bound F− ions (magenta). The Eca 
model is complete except for 7 N-terminal and 3–4 C-terminal disordered residues. b. 
Extracellular (left) and intracellular views of Eca, with monobodies removed. c. A single 
Eca subunit, with aqueous vestibules shown in blue mesh.
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Figure 3. Ion-coupling region of Eca
a. WT, showing F− ions (magenta spheres) and Glug (orange stick). b. Detail of WT F−ex 
coordination. c. Same region for E118Q.
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Figure 4. F− block of Cl− flux in Glug mutants
a. Raw traces of Cl− flux in Glug mutants at indicated F− concentration added to both sides 
of the liposomes. Turnover defined as in Fig 1a. b. F− inhibition of Cl− efflux initial rate 
through E118A (filled points) or E118Q (open points), normalized to the rate at zero F−. 
Curve represents hyperbolic fit to both datasets, with Ki = 20 μM.
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Figure 5. Ion accessibility of WT Eca and V319G mutant
a. Ion-coupling region of V319G. F− (magenta) is observed in only one of the two Eca 
subunits at this resolution. Glug (orange stick) adopts the Down rotamer, its carboxylate 
occupying the central anion-binding site. b. Intracellular and extracellular surface 
representations of WT and V319G single subunits, viewed from indicated sides, showing 
solvent accessibility of bound F− (magenta) or Glug carboxyl oxygens (red).
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Figure 6. F−/H+ antiport model
a. Cross-sectional view of WT (upper) or V319G (lower) structure, with aqueous vestibules 
colored pink or blue to indicate F− or H+ accessibility, respectively. Occluded F− position in 
V319G is shown as pink circle. b. Proposed transport cycle depicting WT (top) and V319G 
(right) structures along with a hypothetical conformation (left) based upon CLC-ec1 
transporter with Glug in Middle position. F− ions are magenta, H+ are blue, and Glug is 
orange. Cycle is shown for net F− export; clockwise trajectory of Glug sidechain, with 
rotamers in Up, Middle, and Down positions is shown in center of the diagram.
Last et al. Page 18
Nat Struct Mol Biol. Author manuscript; available in PMC 2019 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Last et al. Page 19
Table 1
Unitary ion turnover rates in Eca and indicated mutants
Construct F− efflux Cl− efflux H+ influx
WT 150 ± 10 0 ± 1 125 ± 10
E118D 16 ± 2 −2 ± 3 8 ± 1
E118Q 0 ± 1 350 ± 30 <4
E118A 2 ± 2 370 ± 30 <4
E318Q 8 ± 2 2 ± 1 4 ± 1
E318A 23 ± 4 2 ± 1 15 ± 1
T320A 13 ± 2 1 ± 1 8 ± 1
Y396A 35 ± 6 1 ± 1 39 ± 4
V319G 50 ± 2 3 ± 1 23 ± 2
Initial rates of ion transport, determined by ion-specific electrodes in proteoliposome suspension, are tabulated as ions/sec/Eca subunit. Proton flux 
assays were performed under F− conditions except for E118Q/A, which were done under Cl− conditions, as described in Methods.
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Table 2
Data collection and refinement statistics
WT (PDB 6D0J) E118Q (6D0K) V319G (6D0N)
Data collection
Space group P212121 P212121 P212121
Cell dimensions
 a, b, c (Å) 116.98, 126.42, 133.94 118.4, 126.0, 134.2 118.1, 124.8, 135.5
 α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (Å) 49.35-3.00 (3.12-3.00)* 49.73-3.35 (3.55-3.35) 49.67-3.12 (3.26-3.12)*
Rsym or Rmerge 0.073 (3.52) 0.042 (1.91) 0.082 (2.81)
I/σI 19.4 (1.3) 14.5 (1.4) 12.2 (1.3)
CC1/2(%) 1.000 (0.825) 1.000 (0.649) 1.000 (0.699)
Completeness (%) 100.0 (100.0) 99.8 (99.2) 99.9 (99.6)
Redundancy 34.5 (32.8) 8.4 (8.5) 17.6 (17.3)
Refinement
Resolution (Å) 49.35-3.00 49.73-3.35 49.67-3.12
No. reflections 39989 29271 35889
Rwork/Rfree 0.240/0.260 0.244/0.266 0.248/0.270
No. atoms
 Protein 7387 7387 7398
 F− 4 4 1
 Detergent/other 204 204 204
 Water 16 9 11
B-factors
 Protein 152 193 170
 F− 153 172 138
 Detergent/other 186 227 204
 Water 140 163 143
R.m.s. deviations
 Bond lengths (Å) 0.002 0.002 0.002
 Bond angles (°) 0.465 0.462 0.452
Ramachandran favored/outliers (%) 96.2/0.2 96.4/0.2 96.6/0.2
*WT data was merged from measurements of three different positions on the same crystal. V319G dataset was merged from measurements of two 
different positions on the same crystal.
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